Finance

Lists
HCSG:NASDAQ
Healthcare Services Group Inc
$24.90
-0.48%
(-0.12) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HCSG...
Open
$25.00
High
$25.26
Low
$24.81
Mkt. cap
1.68B
Avg. vol.
753.74K
Volume
0.00
P/E ratio
16.75
52-wk high
$27.05
52-wk low
$16.78
EPS
$1.49
Beta
0.92
Shares outstanding
67.43M
No. of employees
36K
Open
$25.00
High
$25.26
Low
$24.81
Mkt. cap
1.68B
Avg. vol.
753.74K
Volume
0.00
P/E ratio
16.75
52-wk high
$27.05
52-wk low
$16.78
EPS
$1.49
Beta
0.92
Shares outstanding
67.43M
No. of employees
36K
News stories
From web sources and news partners
About Healthcare Services Group Inc
CEO-
Employees36K
Founded1976
HeadquartersBensalem Township, Pennsylvania, United States
SectorIndustrials
IndustryService
Analyst ratings
Based on 3 analysts giving stock ratings to HCSG in the past 3 months
Buy
Buy
1
Hold
2
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for HCSG in the last 3 months.
Highest
Current $24.90
$28.00 (+12.45%)
Average
$25.33 (+1.73%)
Lowest
$24.00 (-3.61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$28.00
+12.4%
10/22/2026
Ryan Halsted
RBC Capital
Hold
Maintained
$24.00
-3.6%
10/21/2026
Andrew Wittmann
Robert W. Baird
Hold
Maintained
$24.00
-3.6%
10/08/2026
Sean Dodge
BMO Capital
Hold
Reiterated
$24.00
-3.6%
07/22/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
07/22/2026
A.J. Rice
UBS
Buy
Reiterated
$30.00
+20.5%
07/08/2026
Bill Sutherland
Benchmark Co.
Buy
Maintained
$30.00
+20.5%
04/23/2026
Last report
Oct 21, 2026
Fiscal period
Q3 2026
$0.36 / $0.24
+50.91%beat
Revenue / Est. (USD)
479.60M / 480.79M
-0.25%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
466.68M
462.77M
470.81M
479.60M
Cost of goods sold
394.61M
386.93M
396.02M
399.22M
Cost of revenue
394.61M
386.93M
396.02M
399.22M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46.20M
42.00M
52.58M
48.45M
Operating expense
46.20M
42.00M
52.58M
48.45M
Total operating expenses
440.81M
428.93M
448.60M
447.67M
Operating income
25.88M
33.84M
22.21M
31.94M
Other non operating income
-
-
-
-
EBT including unusual items
28.55M
34.54M
31.00M
33.73M
EBT excluding unusual items
28.38M
34.58M
31.04M
33.81M
Income tax expense
-2.69M
8.48M
8.31M
8.85M
Effective tax rate
-9.43%
24.55%
26.79%
26.24%
Other operating expenses
-
-
-
-
Net income
31.24M
26.06M
22.70M
24.88M
Net profit margin
6.69%
5.63%
4.82%
5.19%
Earnings per share
0.44
0.37
0.32
0.36
Interest and investment income
2.88M
1.11M
9.45M
2.19M
Interest expense
-374.00K
-365.00K
-619.00K
-318.00K
Net interest expenses
2.50M
744.00K
8.83M
1.87M
Depreciation and amortization charges
-
-
-
-
EBITDA
27.74M
35.74M
24.33M
34.09M
Gain or loss from assets sale
169.00K
91.00K
90.00K
132.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps